Tegaderm™ CHG dressing significantly improves catheter-related infection rate in hemodialysis patients

Marco Righetti1, Nicola Palmieri1, Oscar Bracchi1

  • 1Renal Unit, Uboldo Hospital, Cernusco s/N, Milan - Italy.

Insights

Tegaderm™ chlorhexidine gluconate (CHG) dressing significantly reduced catheter-related infections in hemodialysis patients. This intervention lowered infection rates and associated healthcare costs, improving patient outcomes.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Medical Devices

Background:

  • Catheter-related infections pose a significant clinical challenge for patients undergoing maintenance hemodialysis.
  • These infections negatively impact patient survival, increase hospitalization rates, and escalate healthcare costs.
  • Preventive strategies are crucial to mitigate the burden of catheter-related infections in this vulnerable population.

Purpose of the Study:

  • To evaluate the efficacy of Tegaderm™ chlorhexidine gluconate (CHG) dressing in reducing catheter-related infections among hemodialysis patients.
  • To compare the incidence of catheter-related infections using CHG dressing versus standard dressings.
  • To assess the impact of CHG dressing on catheter-related bloodstream infection rates and associated healthcare expenditures.

Main Methods:

  • A prospective, randomized, cross-over study design was employed.
  • The study involved two treatment periods of six months each, comparing Tegaderm™ CHG dressing with standard dressing.
  • The primary outcome measured was the catheter-related infection rate, with 59 prevalent hemodialysis patients enrolled.

Main Results:

  • A significant reduction in the overall catheter-related infection rate was observed, decreasing from 1.21 to 0.28 per 1000 catheter days with CHG dressing (p = 0.02).
  • Catheter-related bloodstream infection rates decreased from 0.65 to 0.09 per 1000 catheter days (p = 0.05) in patients using CHG dressing.
  • Estimated annual healthcare costs associated with catheter-related bloodstream infections were substantially lower with CHG dressing (EUR62,459) compared to standard dressing (EUR300,399).

Conclusions:

  • This prospective study provides the first evidence that Tegaderm™ CHG dressing significantly reduces catheter-related infection rates in hemodialysis patients.
  • The findings suggest that CHG dressing is an effective intervention for improving patient safety and reducing the economic burden of infections in this population.
  • Implementing CHG dressings can be a valuable strategy for infection control in hemodialysis settings.
Abstract

Related Concept Videos

Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
526
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.6K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.8K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.3K
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.7K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.2K